Advances in 3D neuronal microphysiological systems: towards a functional nervous system on a chip
January 12, 2021 AxoSim published a review paper with Springer Nature’s In Vitro Cellular & Developmental Biology – Animal on […]
January 12, 2021 AxoSim published a review paper with Springer Nature’s In Vitro Cellular & Developmental Biology – Animal on […]
December 10, 2020 We present a nontraditional fabrication technique for the realization of three-dimensional (3D) microelectrode arrays (MEAs) capable of
BENSON CAPITAL PARTNERS ANNOUNCES FIRST INVESTMENT IN AXOSIM, INC. AxoSim, Inc, Provider of BrainSim™ and NerveSim™ Neurological Drug Discovery Platforms
Benson Capital Partners Announces First Investment in AxoSim Read more
–Two grants from the DoD Congressionally Directed Medical Research Program and the National Institutes of Health awarded to AxoSim– –The
AxoSim Announces the Award of over $870,000 in Federal Grants Read more
February 21. 2020 Selective serotonin reuptake inhibitors (SSRIs) are frequently used to treat depression during pregnancy. Various concerns have been
July 15, 2020 Organ-on-a-chip devices that mimic in vivo physiology have the potential to identify effects of chemical and drug exposure in
May 11, 2020 Recent publication in ALTEX demonstrates prediction of clinical peripheral neuropathy by chemotherapeutic drugs using NerveSim™ powered by
Publication Confirms NerveSim’s Ability to Recapitulate Peripheral Neuropathy Read more
AxoSim Chief Science Officer and Co-Founder, Dr. Michael J. Moore, presented Nerve-on-a-Chip pain model at the NIH Tissue Chips Consortium
AxoSim Co-Founder, Dr. Michael J. Moore, Presents at NIH Tissue Chips Consortium Read more
We are excited to announce that our paper, “Engineering a 3D functional human peripheral nerve in vitro using the Nerve-on-a-Chip®
AxoSim’s Article in Top 100 Neuroscience Paper Downloads of 2019 Read more